EDGAR Filing Documents for 0001395064-24-000088

Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:

SEC Accession No. 0001395064-24-000088

Filing Date

2024-06-26

Accepted

2024-06-26 08:26:13

Documents

Effectiveness Date

2024-06-26

Document Format Files

Seq	Description	Document	Type	Size
1	F-3ASR	f-3asr_062624.htm	F-3ASR	240575
2	EX-FILING FEES	exhibit107_062624.htm	EX-FILING FEES	33844
3	EX-1.1	exhibit11_062624.htm	EX-1.1	303294
4	EX-5.1	exhibit51_062624.htm	EX-5.1	8687
5	EX-5.2	exhibit52_062624.htm	EX-5.2	21709
6	EX-23.1	exhibit231_062624.htm	EX-23.1	2143
7	EX-25.1	exhibit251_062624.htm	EX-25.1	57383
8	GRAPHIC	imagea.jpg	GRAPHIC	16255
	Complete submission text file	0001395064-24-000088.txt		691169

Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668

Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111

TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: F-3ASR | Act: 33 | File No.: 333-280469 | Film No.: 241070693
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)